Principal Financial Group’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,117
| Closed | -$15K | – | 2509 |
|
|
2022
Q1 | $15K | Sell |
11,117
-626
| -5% | -$845 | ﹤0.01% | 2530 |
|
|
2021
Q4 | $21K | Sell |
11,743
-7,621
| -39% | -$13.6K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $42K | Sell |
19,364
-13,164
| -40% | -$28.6K | ﹤0.01% | 2542 |
|
|
2021
Q2 | $114K | Sell |
32,528
-6,625
| -17% | -$23.2K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $386K | Sell |
39,153
-646
| -2% | -$6.37K | ﹤0.01% | 2211 |
|
|
2020
Q4 | $431K | Buy |
39,799
+12,538
| +46% | +$136K | ﹤0.01% | 2147 |
|
|
2020
Q3 | $281K | Sell |
27,261
-98
| -0.4% | -$1.01K | ﹤0.01% | 2141 |
|
|
2020
Q2 | $571K | Buy |
27,359
+17,276
| +171% | +$361K | ﹤0.01% | 1940 |
|
|
2020
Q1 | $99K | Buy |
+10,083
| New | +$99K | ﹤0.01% | 2118 |
|
|
2019
Q2 | – | Sell |
-22,024
| Closed | -$115K | – | 2227 |
|
|
2019
Q1 | $115K | Buy |
22,024
+223
| +1% | +$1.16K | ﹤0.01% | 2151 |
|
|
2018
Q4 | $69K | Sell |
21,801
-19,327
| -47% | -$61.2K | ﹤0.01% | 2187 |
|
|
2018
Q3 | $249K | Buy |
41,128
+767
| +2% | +$4.64K | ﹤0.01% | 2120 |
|
|
2018
Q2 | $214K | Buy |
+40,361
| New | +$214K | ﹤0.01% | 2150 |
|
|
2015
Q3 | – | Sell |
-17,503
| Closed | -$285K | – | 2185 |
|
|
2015
Q2 | $285K | Sell |
17,503
-9,397
| -35% | -$153K | ﹤0.01% | 1965 |
|
|
2015
Q1 | $1.09M | Hold |
26,900
| – | – | ﹤0.01% | 1754 |
|
|
2014
Q4 | $1.45M | Buy |
+26,900
| New | +$1.45M | ﹤0.01% | 1739 |
|